Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -118.36% | $ -57.49M | $ 48.58M |
3/31/2025 | -166.23% | $ -74.11M | $ 44.58M |
12/31/2024 | -152.91% | $ -73.36M | $ 47.98M |
9/30/2024 | -1.04% | $ -1.1M | $ 106.45M |
6/30/2024 | 13.13% | $ 15.55M | $ 118.46M |
3/31/2024 | 19.58% | $ 21.73M | $ 110.98M |
12/31/2023 | 20.7% | $ 21.48M | $ 103.78M |
9/30/2023 | -4.02% | $ -3.13M | $ 77.7M |
6/30/2023 | -24.02% | $ -13.03M | $ 54.23M |
3/31/2023 | -49% | $ -26.22M | $ 53.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for SPERO THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -86.2M ] / Revenues [ $ 11.05M ]
(=) Operating % [ -779.88% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |